Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, is launching its fifth annual fundraising challenge with Glaucoma Research Foundation (GRF) during Glaucoma Awareness Month in January. Bausch + Lomb will also sponsor The Glaucoma Foundation’s (TGF) social media campaign to raise awareness of the disease and its impact by highlighting a glaucoma patient or advocate every day in January.
“Currently, about four million people in the United States are affected by glaucoma, and this number is only expected to grow as the population ages,” said Andrew Stewart, president, Global Pharmaceuticals and International Consumer, Bausch + Lomb. “Our collaborations with GRF and TGF will advance education and research efforts designed to improve the lives of those affected by glaucoma and encourage everyone to be proactive when it comes to eye health.”
As part of the fundraising challenge with GRF, Bausch + Lomb will match every dollar raised during January, up to $20,000. All proceeds will support critical research for glaucoma, a leading cause of irreversible blindness in the U.S.1
“Glaucoma often progresses without noticeable symptoms, making research and improved education vital to saving sight,” said Thomas M. Brunner, president and CEO, Glaucoma Research Foundation. “Our continued partnership with Bausch + Lomb supports our efforts to accelerate the discoveries that can make a real difference for people living with this disease.”
Learn more about GRF or make a donation at www.glaucoma.org.
TGF’s social media campaign aims to put a human face to the disease, raise awareness and stress the importance of early detection by sharing personal stories from a patient or advocate each day during the month of January.
“Due to the chronic, progressive nature of glaucoma, early intervention can mean the difference between saving and losing sight,” said Elena Sturman, president and CEO, The Glaucoma Foundation. “In partnership with Bausch + Lomb, our campaign will showcase real-world experiences with glaucoma, create greater awareness and bring hope to those affected by this disease.”